Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

45 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

NCT02112656

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Toronto General Hospital Toronto, Ontario, Canada
  • Mengchao Hepatobiliary Hospital of Fujian Medicatl University Fuzhou, Fujian, China
  • Xijing Hospital Xi'an, Shaanxi, China
View all 61 locations
View Trial Details
Completed

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

NCT02993731

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute (CCI) Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
View all 267 locations
View Trial Details
Completed

A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer

NCT02753127

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +11 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 211 locations
View Trial Details

Related conditions